WeChat Mini Program
Old Version Features

Immunogenicity and Safety of SARS-CoV-2 Recombinant Spike Protein Vaccine in South African People Living with and Without HIV-1 Infection: A Phase 2 Randomised Trial

JOURNAL OF INFECTION(2024)

Cited 0|Views2
Key words
COVID-19,Vaccine,Immunosuppression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined